Insights

What is Your Data Integration and Analytics Platform Strategy?

If I Could Only Ask Two Questions, the First One Would Be: What is Your Data Integration and Analytics Platform Strategy? It’s really simple, data analytics drives decisions. In the healthcare industry, we use data to…

A Patient Hero

Articles

Innovative Therapies Call for an Integrated Drug Safety and Compliance Model

In this article, Herbert Lee, PharmD, Senior Vice President, Medical Communications and Pharmacovigilance, makes the case for an integrated approach to ensuring the safe and effective use of medications by patients. From emerging therapies to innovative…

Navigating Channel Distribution in a New (and more complex) Biopharma World

Every twist and turn in the bench-to-bedside commercialization journey introduces increasing regulatory complexity, product-specific special handling requirements, and evolving industry guidelines. With more than 300 client case studies to draw from, we’ve found three opportunities (or…

Patients at the Center of Safe and Effective Therapy

First, do no harm. This phrase is synonymous with the Hippocratic oath, the oldest reference to ethics in Western medicine, and it highlights what is generally considered most important in a physician’s medical practice. Help if…

Eight Powerful Strategies Business Leaders Can Build on for Success

Sandra Shpilberg shared insight in a Silicon Valley Business Journal’s article focused on “Eight Powerful Strategies Business Leaders Can Build on for Success.” The article is part of the Journal’s invite-only Leadership Trust panel of influential…

Are You Ready For Patient Services 2.0?

Today’s patients are far more engaged than the previous era of “doctor knows best.” And, like all modern consumers, they expect outcomes to be personalized, delivered on their terms, powered by technology, and of high value.…

Building a Service Offering from the Research Lab to the Patient’s Home

A Conversation with Pharmaceutical Commerce & Jim Lang, Chief Executive Officer, EVERSANA Not quite a year ago, an assemblage of pharma service providers came into being as EVERSANA. Funded by two private equity firms with a…

Are We Transforming In The Right Way?

Why Product Launches Can’t Be Distracted By Empty Promises. We can all agree that innovations in therapeutic development have advanced beyond traditional product launch strategies and service models. In every step of the product lifecycle, we…

Power in numbers: Seven national plans manage almost half of the medical lives in the U.S.

Market Access Macrotrends provides  insight for you to stay on top of market access trends, anticipate how the healthcare landscape is evolving, and provide strategic guidance for your organization. Market Access Macrotrends answers your questions about changes in…

A More Trusting Relationship Can Lead to a Better Patient Experience

In this September feature, PM360 dives into what it takes to create relationships and experiences with and for patients. Considering that patients want more authentic interactions when dealing with life sciences companies, Jenny Sparano, director of…

Driving the Commercialization of Regenerative Medicine

With more than 7,000 distinct types of rare and genetic diseases and 400+ million individuals suffering from a rare disease, regenerative medicine holds the hope for a cure – transforming healthcare by revolutionizing patient care from…